Progyny, Inc.

NASDAQ:PGNY

Medical - Healthcare Information Services

Healthcare
$36.16 -0.19%

-$0.05 today

Market cap
$2.66B
Beta
1.04
P/E (TTM)
31.4
EPS (TTM)
$0.84
52W Low $16.10High $28.75

Volume 0.88M

Average 1.49M

PGNY Other Working Capital

Cash effect of changes in other operating assets and liabilities.

Progyny, Inc.NASDAQ: PGNY

Other Working Capital · Q2 FY2026 · quarter ended Jun 2026

Other working capital turns positive

Q2 FY2026 other working capital was $8.55M, compared with -$17.64M a year earlier. Trailing-twelve-month other working capital was -$313K.

Context

  • Other working capital amounted to 1.6% of revenue in FY2025, down 0.8 pp from a year earlier.
  • Other working capital increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other working capital holds near $8.55M or moves back toward the trailing-twelve-month quarterly average of -$78.25K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$8.55M-2.0% QoQ
Last fiscal yearDec 2025
-$20.84M-173.5% YoY
LTMJun 2026
-$313K-102.1% YoY
Other Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+148.5%——
1 year-173.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Working Capital history

USD · from the cash flow

Latest · FY2025
(20.84M) USD
Year-over-year change
-173.5%

Other Working Capital vs competitors

How PGNY compares with its peers on the latest reported figures

  • PGNY's LTM Jun 2026 other working capital of $313K is the smallest of the 3 companies compared; the peer median is $6.21M.
  • Its year-over-year change of -102.1% is the lowest of 3, against a peer median of +163.8%.
  • Other working capital amounts to 0.0% of revenue for PGNY, versus a peer median of 1.5%.
PGNY Competitors Peer median
Other Working Capital for PGNY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OMDAOmada HealthLTM Mar 2026$7.77M +213.6%+85.4%2.7%
HQYHealthEquity, Inc.LTM Jul 2026$4.65M +114.0%—0.3%
PGNYProgyny, Inc.LTM Jun 2026$313K -102.1%—0.0%
Peer median (excluding PGNY) $6.21M+163.8%+85.4%1.5%

Competitors are the stored peer set for PGNY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income65.77M30.36M62.04M54.34M58.52M
Depreciation & Amortization1.3M1.6M2.28M3.18M4.95M
Deferred Income Tax(33.3M)(6.62M)3.75M(10.46M)(8.12M)
Stock-Based Compensation33.71M100.75M122.61M128.13M131.87M
Change in Working Capital(51.26M)(59.49M)(17.42M)(11.78M)2.8M
Accounts Receivables(68.68M)(119.3M)(21.74M)(9.87M)(5.12M)
Inventory00000
Accounts Payables17.84M47.69M16.24M(30.27M)28.75M
Other Working Capital(421K)12.12M(11.92M)28.37M(20.84M)
Other Non-Cash Items9.82M13.79M15.56M15.7M20.17M
Operating Cash Flow26.04M80.4M188.81M179.11M210.19M
Capital Expenditures(2.13M)(3.24M)(3.64M)(5.41M)(18.41M)
Acquisitions (Net)000(5.3M)(9.34M)
Purchases of Investments(111.48M)(163.33M)(429.69M)(170.34M)(354.96M)
Sales of Investments122.37M122.71M232.81M376.84M223.7M
Other Investing Activities00000
Investing Cash Flow8.77M(43.87M)(200.53M)195.79M(159.01M)
Debt Repayment00000
Common Stock Issued4.27M4.23M6.13M2.4M1.23M
Common Stock Repurchased000(300.28M)(81.66M)
Dividends Paid00000
Other Financing Activities(17.97M)(12.09M)(17.2M)(12M)(18.94M)
Financing Cash Flow(13.7M)(7.86M)(11.07M)(309.88M)(99.36M)
Effect of Forex Changes001K1K62K
Net Change in Cash21.11M28.67M(22.78M)65.02M(48.12M)
Free Cash Flow23.91M77.15M185.17M173.7M191.78M

Progyny, Inc.

NASDAQ:PGNY

Intrinsic Alpha fair value

Locked

Current Price

$36.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.